You are here

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
PRMT5 reduces immunotherapy efficacy in triple-negative breast cancer by methylating KEAP1 and inhibiting ferroptosis

 

Online download statistics by month:

Online download statistics by month: June 2023 to February 2026

AbstractFullPdf
Jun 202322823053
Jul 2023478481244
Aug 2023280287101
Sep 202317317373
Oct 2023161161100
Nov 2023182182122
Dec 2023159160122
Jan 2024181182133
Feb 2024142142101
Mar 2024211214157
Apr 2024202205155
May 2024253253117
Jun 202414814894
Jul 2024158159127
Aug 202411211190
Sep 2024131131101
Oct 2024234236174
Nov 2024228229173
Dec 2024285292169
Jan 2025175177119
Feb 2025267271242
Mar 2025258259190
Apr 2025284284219
May 2025214214169
Jun 202510911070
Jul 2025110
Feb 2026110
Total525552933415